C.J. Ciaramella, a reporter at Reason magazine with ADHD, shares his struggles with medication shortages caused by strict government regulations. Psychiatrist Julie Holland discusses the FDA's refusal to approve MDMA-assisted therapy for PTSD, emphasizing how it restricts treatment options for traumatized patients. Meanwhile, Anne Bradley dives into the complex issues surrounding insulin pricing and access, shedding light on how government policies impact healthcare markets. Together, they highlight the broader ramifications of regulatory hurdles on patient care.

Mike Abell, a devoted father navigating his son's rare brain cancer, joins Dr. Shannon MacDonald, a telemedicine expert. They discuss the crucial role of telehealth in overcoming healthcare barriers, highlighting how archaic laws complicate access to vital treatments. Abell emphasizes the emotional toll on families, while MacDonald sheds light on how these regulations clash with physicians' ethical duties. Together, they call for legal reforms to enhance patient care and ensure that innovative medicine can truly reach those in need.

Jennifer Erickson, a senior fellow at the Federation of American Scientists, sheds light on the dire state of organ donation in the U.S. She reveals that about 28,000 potential organs go uncollected annually, with 17,000 kidneys lost in the shuffle. Monopolistic inefficiencies within the system lead to wasted organs and longer waiting lists for patients. Erickson advocates for accountability and ethical incentives, such as tax credits, to boost kidney donations and alleviate the crisis facing many Americans in need of transplants.

Dr. Jay Singleton, a dedicated medical professional, discusses his battle to establish a new cataract surgical center in North Carolina amidst daunting Certificate of Need laws. He shares a captivating encounter with hospital officials that turned confrontational. With attorney Joshua Windham, they delve into how these regulations stifle healthcare innovation, leading to higher costs for patients. The conversation highlights the collective struggle against bureaucratic barriers, advocating for regulatory reform to enhance patient access and care.

Dive into the murky waters of healthcare regulations and discover how Certificate of Need laws stifle access to vital services. Hear the heartbreaking story of a mother fighting for a birthing center in Georgia amid overwhelming bureaucratic barriers. Explore the case of an ophthalmologist grappling with restrictive laws that limit his ability to serve patients. These narratives emphasize the urgent need for reform in healthcare to prioritize patient access and quality over regulatory red tape.

Mark Cuban, a serial entrepreneur and Shark Tank investor, discusses the shocking prices of prescription drugs in the U.S. He emphasizes the lack of transparency as a root cause of inefficiency in the market. Cuban shares his vision with CostPlusDrugs.com, aiming to reshape drug pricing by offering low-cost pharmaceuticals directly to consumers. The conversation dives into the controversial price hikes of medications like Daraprim and critiques the role of pharmacy benefit managers, advocating for reforms to make healthcare more accessible.

What's wrong with American health care? That's the question that drives the new season of Why We Can't Have Nice Things, the Reason limited-run podcast series. Over the past few months, host Eric Boehm has been speaking with some of the doctors, medical professionals, and activists who are pushing back against the special interests, government contractors, and bad laws that make the American health care system such a mess. Some of those problems are obvious. Prescription drugs are often too expensive and sometimes not available when you need them. Others are less obvious, such as a series of state-level regulations that make it harder for medical professionals to offer their services. Or a monopoly government contractor that's a big part of the reason why thousands of Americans die every year waiting for a new kidney. On the new season of Why We Can't Have Nice Things, you'll hear a whole new set of stories about how the government is making Americans poorer and sicker, and how we can cure those ills.  It all kicks off next Thursday, September 5, with special guest Mark Cuban. He's the co-founder of Cost Plus Drugs, an innovative attempt to inject some market competition into the prescription drug industry. Tune in to new episodes every Thursday through October 10—and if you haven't listened to the first season of the show, check it out now on Spotify and Apple Podcasts.  Producer: Hunt BeatyThe post Trailer: <em>Why We Can't Have Nice Things</em> Season 2 appeared first on Reason.com.

The podcast discusses the fight over tariffs on imported tinplate steel, which could lead to reduced supply and higher prices. The potential consequences include job loss, increased imports from Mexico, and a 19 to 30 percent increase in food prices. The podcast also highlights the biased and unfair tariff process, the influence of lobbying groups, and the detrimental effects of protectionism.

The podcast explores the history and impact of the 'Chicken Tax', a 25% tariff on imported light trucks. It discusses how the tariff has limited competition, increased prices for consumers, and led to attempts at tax evasion. The podcast also examines the challenges of removing the 'Chicken Tax' and the unintended consequences of trade wars.

Explore Arkansas' strange liquor laws, where existing liquor stores and churches campaign to prevent the retail sale of alcohol. Public choice theory explains the unusual alliance between liquor stores and churches. The podcast dives into the restrictions and dynamics of the alcohol industry, the perception and regulations surrounding different alcohol types, and the influence of religious and economic factors on liquor sales in Texas and Arkansas.